Research
Molecular Regulation of Lipid Metabolism in Health and Disease
Lipids are essential components of cells and play important roles in energy storage, membrane formation, and cellular signaling. Maintaining lipid homeostasis requires cells to precisely coordinate lipid synthesis with nutritional and hormonal conditions. Dysregulation of these processes contributes to metabolic diseases, including obesity, type 2 diabetes, fatty liver disease, and cardiovascular disease.
Our laboratory investigates the molecular mechanisms by which hormonal and nutritional signals regulate lipid metabolism in health and disease. A major focus of our research is the sterol regulatory element-binding proteins (SREBPs), a family of membrane-bound transcription factors that control the synthesis of fatty acids, triglycerides, and cholesterol. We are particularly interested in understanding the molecular events through which insulin, glucagon, and dietary fatty acids regulate SREBP activity, including signaling pathways, protein-protein interactions, transcriptional regulation, and post-translational modifications such as phosphorylation.
By combining molecular, biochemical, and cellular approaches with primary cells and genetically engineered animal models, we aim to define fundamental mechanisms that coordinate lipid synthesis with the metabolic state of the organism, understand how their dysregulation contributes to metabolic disease, and identify potential targets for therapeutic intervention.
Meet the PI and Lab Members
Jing Tian, Ph.D.
Dr. Jing Tian earned her Ph.D. from Weill Medical College of Cornell University, where she studied intermediary metabolism and antioxidant defense in Mycobacterium tuberculosis with Dr. Carl Nathan. She then completed a postdoctoral fellowship at Johns Hopkins University with Dr. Solomon Snyder, where her research focused on protein S-nitrosylation and neuronal cell death. She subsequently pursued a second postdoctoral fellowship at UT Southwestern Medical Center with Drs. Michael Brown and Joseph Goldstein, where she studied insulin regulation of SREBP-1c and hepatic lipid metabolism.
Dr. Tian is now an Assistant Professor in the Department of Molecular Genetics at UT Southwestern Medical Center. Her research focuses on understanding the molecular mechanisms that regulate hepatic lipid metabolism, particularly how hormones and dietary nutrients control SREBP-dependent lipid synthesis. Her laboratory seeks to identify signaling pathways and molecular events that connect nutritional and hormonal signals to the regulation of lipid metabolism and to understand how disruption of these pathways contributes to metabolic disease.
Publications
Insulin induction of SREBP-1c in rodent liver requires LXRa-C/EBP? complex.
Tian J, Goldstein JL, Brown MS 2016 Jul Proc. Natl. Acad. Sci. U.S.A. 29 113 8182-7S-nitrosylation/activation of COX-2 mediates NMDA neurotoxicity.
Tian J, Kim SF, Hester L, Snyder SH 2008 Jul Proc. Natl. Acad. Sci. U.S.A. 30 105 10537-40Contact Us
Email: jing.tian@utsouthwestern.edu
Phone: 214-648-2687
Mailing Address
Department of Molecular Genetics
UT Southwestern Medical Center
5323 Harry Hines Blvd.
Dallas, TX 75390-9046
Physical Address
L5.250